Fosfomycin/tobramycin combinations for the treatment and prevention of ophthalmic, otological and dermatological infections

Details for Australian Patent Application No. 2009307875 (hide)

Owner Gilead Sciences, Inc.

Inventors Macleod, David

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009307875

PCT Pub. Number WO2010/048059

Priority 61/107,242 21.10.08 US

Filing date 16 October 2009

Wipo publication date 29 April 2010

International Classifications

A61K 31/665 (2006.01) - having oxygen as a ring hetero atom, e.g. fosfomycin

A61K 31/7036 (2006.01)

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/048059 Priority application(s): WO2010/048059

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009307876-Mechanism of structural formation for metallic glass based composites exhibiting ductility

2009307869-Ergonomic spray can adapter and positioning apparatus